BRIZZI, ANTONELLA
 Distribuzione geografica
Continente #
EU - Europa 3.567
NA - Nord America 3.204
AS - Asia 406
OC - Oceania 11
SA - Sud America 9
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.201
Nazione #
US - Stati Uniti d'America 3.189
GB - Regno Unito 1.143
IT - Italia 733
IE - Irlanda 633
CN - Cina 332
SE - Svezia 297
UA - Ucraina 229
FR - Francia 190
DE - Germania 186
FI - Finlandia 85
TR - Turchia 28
BE - Belgio 13
ES - Italia 13
AU - Australia 11
IN - India 11
VN - Vietnam 10
CA - Canada 9
RU - Federazione Russa 9
PK - Pakistan 6
PL - Polonia 6
CL - Cile 5
MX - Messico 5
SI - Slovenia 5
HK - Hong Kong 4
JP - Giappone 4
NL - Olanda 4
AT - Austria 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
CZ - Repubblica Ceca 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
RO - Romania 2
AM - Armenia 1
AR - Argentina 1
BR - Brasile 1
CH - Svizzera 1
CO - Colombia 1
DZ - Algeria 1
EU - Europa 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
JO - Giordania 1
LK - Sri Lanka 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 7.201
Città #
Southend 1.081
Dublin 631
Fairfield 498
Siena 262
Chandler 258
Menlo Park 252
Ashburn 238
Woodbridge 231
Wilmington 196
Jacksonville 183
Seattle 162
Houston 155
Cambridge 143
Ann Arbor 138
Princeton 108
Beijing 106
Nanjing 77
Fremont 51
Helsinki 48
Florence 40
Milan 40
San Mateo 38
Dearborn 30
Izmir 25
New York 25
Rome 25
San Diego 25
Boardman 24
Nanchang 21
Shanghai 19
Shenyang 18
Düsseldorf 15
London 14
Brussels 12
Hebei 11
Naples 11
Tianjin 11
Dong Ket 10
Kunming 10
Norwalk 10
Redwood City 10
Guangzhou 9
Mogliano 9
Candiolo 8
Venezia 8
Aligarh 7
Anguillara Sabazia 7
Melbourne 7
Mestre 7
Paris 7
Washington 7
Málaga 6
Ningbo 6
Bari 5
Galatone 5
Jinan 5
San Francisco 5
Valencia 5
Arconate 4
Cardiff 4
Chicago 4
Como 4
Empoli 4
Falkenstein 4
Hong Kong 4
Jiaxing 4
Livorno 4
Mestrino 4
Philadelphia 4
Port Talbot 4
Turku 4
Zhengzhou 4
Bologna 3
Gavirate 3
Grünheide 3
Gunzenhausen 3
Hangzhou 3
Krakow 3
Lastra a Signa 3
Menges 3
Montemiletto 3
Montreal 3
Multan 3
Ottawa 3
Porto San Giorgio 3
Sesto Fiorentino 3
Southwark 3
Taizhou 3
Vienna 3
Alezio 2
Bathinda 2
Bollate 2
Boston 2
Cefalù 2
Certaldo 2
Changchun 2
Chongqing 2
Cumiana 2
Decatur 2
Fondi 2
Totale 5.504
Nome #
Ligandi TRPV1 301
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress 270
Quercetin/oleic acid-based G-protein-coupled receptor 40 ligands as new insulin secretion modulators 234
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease 217
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility 197
Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83 192
Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: Involvement of the GABAB and cannabinoid CB1 receptors 188
Nuclear magnetic resonance for studying recognition processes between anandamide and cannabinoid receptors 185
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: An effective scaffold for the design of either CB1 and CB2 receptor ligands 184
New fluoroquinolones active against fluoroquinolones-resistant Mycobacterium tuberculosis strains. 164
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 158
Dihydro-alkylthio-benzyl-oxopyrimidines as Inhibitors of Reverse Transcriptase: Synthesis and Rationalization of the Biological Data on Both Wild-Type Enzyme and Relevant Clinical Mutants 156
Screen of Unfocused Libraries Identified Compounds with Direct or Synergistic Antibacterial Activity 153
Synthesis, Cannabinoid Receptor Affinity, and Molecular Modeling Studies of Substituted 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 151
Synthesis and biological evaluation of New N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands 144
Rapid combinatorial access to a library of 1,5-disubstituted-3-indole-N-alkylacetamides as CB2 receptor ligands 143
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 6. Synthesis and Pharmacological Evaluation of 7-Substituted 4-Quinolone-3-carboxamide Derivatives as High Affinity Ligands for Cannabinoid Receptors 140
Synthetic bioactive olivetol-related amides: the influence of the phenolic group in cannabinoid receptor activity 139
Synthesis and antitumor activities of a series of novel quinoxalinhydrazides 138
New Resorcinol-Anandamide "Hybrids" as Potent Cannabinoid Receptor Ligands Endowed with antinociceptive activity in vivo 136
Nuovi Potenti e Selettivi ligandi dei recettori dei cannabinoidi 136
Regioselective functionalization of quinolin-4(1H)-ones via sequential palladium-catalyzed reactions 135
Development and characterization of immobilized cannabinoid receptor (CB1/CB2) open tubular column for on-line screening. 133
TRPV1-FAAH-COX: The Couples Game in Pain Treatment 133
Synthesis and in vitro pharmacological activity of oxypropanol analogs of labetalol 132
Active manganese dioxide promoted cyclization of ortho-(1H-pyrrol-1-yl)aryl and heteroaryl carboxylic acids to 5H-pyrrolo[1,2-a][3,1]benzoxazin-5-one derivatives 129
HIV-Reverse Transcriptase Inhibition: Inclusion of Ligand-Induced Fit by Cross-Docking Studies 126
Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile. 124
Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors 123
Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol (2-AG) Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 (CB1) Receptor 122
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist 122
Thiazolothiazepine Inhibitors of HIV-1 Integrase 115
Polycondensed Heterocycles. Part 11: Preparation and Regioselective Reductions of 5-Phenyl-4H-pyrrolo[1,2-a][1]benzazepin-4-one 111
Design, Synthesis, and Binding Studies of New Potent Ligands of Cannabinoids Receptors 108
A multitarget semi-synthetic derivative of the flavonoid morin with improved in vitro vasorelaxant activity: Role of CaV1.2 and KCa1.1 channels 105
Pinocembrin and its linolenoyl ester derivative induce wound healing activity in HaCaT cell line potentially involving a GPR120/FFA4 mediated pathway 103
3-Amino-alkylated indoles: Unexplored green products acting as anti-inflammatory agents 101
In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands 96
Identification and Quantification of Trans-Resveratrol in Dietary Supplements by a Rapid and Straightforward RP-HPLC Method 92
Design, synthesis and pharmacological evaluation of ester-based quercetin derivatives as selective vascular KCa1.1 channel stimulators 90
Synthesis of pyrazolo[1,5-a]pyrimidine ring as a possible bioisosteric replacement of the 5-(1H-pyrrol-1-yl)pyrazole scaffold 89
Conformational Analysis of the N-Arachinylethanolamide (Anandamide) using Nuclear Magnetic Resonance and Theoretical Calculations 87
Anti-addictive properties of COR659 – Additional pharmacological evidence and comparison with a series of novel analogues 84
An approach to the stereo-controlled synthesis of polycyclic derivatives of L-4-thiazolidinecarboxilic acid active against HIV-1 integrase 84
Napthoxazepine Inhibitors of HIV-1 Integrase: Synthesis and Biological Evaluation 76
Targeting neuropathic pain: Pathobiology, current treatment and peptidomimetics as a new therapeutic opportunity 72
Suppressing effect of the novel positive allosteric modulator of the GABAB receptor, COR659, on locomotor hyperactivity induced by different drugs of abuse 72
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists 70
GPR120/FFAR4 pharmacology: focus on agonists in Type 2 diabetes mellitus drug discovery 70
Design, synthesis and biological evaluation of light-driven on-off multitarget AChE and MAO-B inhibitors 69
Old strategies and new perspectives in modulating the endocannabinoid system 69
Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7‐Hydroxy-5-oxopyrazolo[4,3‐b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo 66
Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors 65
New synthesis of N1- and N2-substituted pyrazolo[4,3-b]pyridine-5-one derivatives as CB2 receptor ligands 59
Design, Synthesis and In Vitro Experimental Validation of Novel TRPV4 Antagonists Inspired by Labdane Diterpenes 56
2-hydroxy-4-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl(E)-3-(4-hydroxy-3-methoxyphenyl)acrylate: synthesis, in silico analysis and in vitro pharmacological evaluation 52
Lipoic/Capsaicin-Related Amides: Synthesis and Biological Characterization of New TRPV1 Agonists Endowed with Protective Properties against Oxidative Stress 51
null 51
Structure optimization of positive allosteric modulators of GABAB receptors led to the unexpected discovery of antagonists/potential negative allosteric modulators 48
Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant Acinetobacter baumannii 47
The GABAB receptor positive allosteric modulator COR659: In vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives 40
Development of 1-(2-aminophenyl)pyrrole-based amides acting as human topoisomerase I inhibitors 30
Totale 7.333
Categoria #
all - tutte 22.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019352 0 0 0 0 0 0 0 0 0 0 185 167
2019/20201.185 154 37 63 179 87 107 89 129 86 127 48 79
2020/20211.320 42 101 38 122 64 134 91 169 125 245 116 73
2021/20221.054 84 121 97 102 64 41 50 55 45 113 96 186
2022/20231.175 82 92 180 141 103 230 45 93 92 29 60 28
2023/20241.020 58 24 98 64 64 245 372 36 18 40 1 0
Totale 7.333